Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. (Q46539253)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2005

Language	Label	Description	Also known as
English	Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.	scientific article published in June 2005

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

Christopher Griffiths

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

A B Gottlieb

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

V C Ho

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

M Lahfa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

U Mrowietz

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

D F Murrell

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

J-P Ortonne

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

G Todd

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

R Cherill

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

I Marks

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

S Emady-Azar

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Multi-Centre Investigator Group

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

British Journal of Dermatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

152

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1219-1227

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Psoriasis--epidemiology and clinical spectrum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Psoriasis: current perspectives with an emphasis on treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

The pathogenesis of psoriasis: immunological facts and speculations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Recombinantly engineered human proteins: transforming the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Development of diabetes mellitus following kidney transplantation: a Canadian experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

A randomized trial of etanercept as monotherapy for psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Long-term safety of cyclosporine in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06661.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2005.06661.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948985%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46539253&oldid=2126436848"